MAAS BIOLAB Trademark

Trademark Overview

On Tuesday, December 7, 2004, a trademark application was filed for MAAS BIOLAB with the United States Patent and Trademark Office. The USPTO has given the MAAS BIOLAB trademark a serial number of 78528668. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, July 9, 2015. This trademark is owned by Maas Biolab, LLC. The MAAS BIOLAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of neurological diseases
maas biolab

General Information

Serial Number78528668
Word MarkMAAS BIOLAB
Filing DateTuesday, December 7, 2004
Status800 - REGISTERED AND RENEWED
Status DateThursday, July 9, 2015
Registration Number3020894
Registration DateTuesday, November 29, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2005

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of neurological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 20, 2004
Primary Code005
First Use Anywhere DateTuesday, April 1, 1997
First Use In Commerce DateTuesday, April 1, 1997

Trademark Owner History

Party NameMaas Biolab, LLC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAlbuquerque, NM 87106
Party NameMaas Biolab, LLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAlbuquerque, NM 87106
Party NameMaas Biolab, LLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAlbuquerque, NM 87122

Trademark Events

Event DateEvent Description
Monday, December 20, 2004NEW APPLICATION ENTERED
Tuesday, July 12, 2005ASSIGNED TO EXAMINER
Monday, July 18, 2005NON-FINAL ACTION WRITTEN
Monday, July 18, 2005NON-FINAL ACTION E-MAILED
Tuesday, July 19, 2005EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 19, 2005EXAMINERS AMENDMENT E-MAILED
Tuesday, July 19, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 22, 2005ASSIGNED TO LIE
Tuesday, July 26, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 17, 2005NOTICE OF PUBLICATION
Tuesday, September 6, 2005PUBLISHED FOR OPPOSITION
Thursday, September 15, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 15, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 30, 2005CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, November 29, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, November 30, 2010TEAS SECTION 8 & 15 RECEIVED
Friday, December 17, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 21, 2010POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, August 19, 2011REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, August 19, 2011TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, August 31, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, August 31, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 7, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 7, 2015TEAS SECTION 8 & 9 RECEIVED
Thursday, May 7, 2015REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Sunday, May 24, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, May 24, 2015POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, July 2, 2015TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, July 9, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 9, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, July 9, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, November 29, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

biolab maas diseases neurological treatment pharmaceuticals